In vitro effect of hydroxyethyl starch 130/0.42 on canine platelet function

American Journal of Veterinary Research

Volumn 73, Issue 12, 2012, Pages 1908-1912

  Classen, Janine ^a   Adamik, Katja N ^b   Weber, Karin ^a   Rubenbauer, Stephanie ^a   Hartmann, Katrin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b VETSUISSE FACULTY UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; HETASTARCH; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DOG; DRUG EFFECT; FEMALE; HEMATOCRIT; IN VITRO STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PLATELETS; DOGS; FEMALE; HETASTARCH; MALE; PLASMA SUBSTITUTES; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; SODIUM CHLORIDE;

CANIS FAMILIARIS;

EID: 84870405524     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.12.1908     Document Type: Article

References (43)

1. Westphal M, James MF, Kozek-Langenecker S, et al. Hydroxyethyl starches: different products-different effects. Anesthesiology 2009;111:187-202.
2. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005;44:681-699.
3. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997;78:974-983.
4. Treib J, Haass A, Pindur G, et al. Influence of intravascular molecular weight of hydroxyethyl starch on platelets. Eur J Haematol 1996;56:168-172.
5. Treib J, Haass A, Pindur G, et al. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 1995;74:1452-1456.
6. von Roten I, Madjdpour C, Frascarolo P, et al. Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation. Br J Anaesth 2006;96:455-463.
7. Treib J, Haass A, Pindur G, et al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996;36:450-455.
8. Treib J, Haass A, Pindur G, et al. Increased haemorrhagic risk after repeated infusion of highly substituted medium molecular weight hydroxyethyl starch. Arzneimittelforschung 1997;47:18-22.
9. Deusch E, Gamsjager T, Kress HG, et al. Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003;97:680-683.
10. Konrad CJ, Markl TJ, Schuepfer GK, et al. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT. Anesth Analg 2000;90:274-279.
11. Kozek-Langenecker SA. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 2005;103:654-660.
12. Franz A, Braunlich P, Gamsjager T, et al. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-1407.
13. Wierenga JR, Jandrey KE, Haskins SC, et al. In vitro comparison of the effects of two forms of hydroxyethyl starch solutions on platelet function in dogs. Am J Vet Res 2007;68:605-609.
14. Smart L, Jandrey KE, Kass PH, et al. The effect of hetastarch (670/0.75) in vivo on platelet closure time in the dog. J Vet Emerg Crit Care (San Antonio) 2009;19:444-449.
15. Mallett SV, Cox DJ. Thrombelastography. Br J Anaesth 1992;69:307-313.
16. Mammen EF, Alshameeri RS, Comp PC. Preliminary data from a field trial of the PFA-100 system. Semin Thromb Hemost 1995;21(suppl 2):113-121.
17. Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998;24:195-202.
18. Callan MB, Giger U. Assessment of a point-of-care instrument for identification of primary hemostatic disorders in dogs. Am J Vet Res 2001;62:652-658.
19. Keidel A, Mischke R. Clinical evaluation of platelet function analyzer PFA-100 in dogs [in German]. Berl Munch Tierarztl Wochenschr 1998;111:452-456.
20. Clemmons RM, Meyers KM. Acquisition and aggregation of canine blood platelets: basic mechanisms of function and differences because of breed origin. Am J Vet Res 1984;45:137-144.
21. Feingold HM, Pivacek LE, Melaragno AJ, et al. Coagulation assays and platelet aggregation patterns in human, baboon, and canine blood. Am J Vet Res 1986;47:2197-2199.
22. Mischke R, Keidel A. Influence of platelet count, acetylsalicylic acid, von Willebrand's disease, coagulopathies, and haematocrit on results obtained using a platelet function analyser in dogs. Vet J 2003;165:43-52.
23. Reinhart WH, Felix C. Influence of propofol on erythrocyte morphology, blood viscosity and platelet function. Clin Hemorheol Microcirc 2003;29:33-40.
24. Clancey N, Burton S, Horney B, et al. Effects of in vitro hemodilution of canine blood on platelet function analysis using the PFA-100. Vet Clin Pathol 2009;38:467-470.
25. Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost 1995;21(suppl 2):106-112.
26. Madjdpour C, Dettori N, Frascarolo P, et al. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics? Br J Anaesth 2005;94:569-576.
27. Driessen B, Brainard B. Fluid therapy for the traumatized patient. J Vet Emerg Crit Care 2006;16:276-299.
28. DiBartola SP. Fluid, electrolyte, and acid-base disorders in small animal practice. St Louis: Elsevier, 2011.
29. Kozek-Langenecker SA, Jungheinrich C, Sauermann W, et al. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials. Anesth Analg 2008;107:382-390.
30. Van der Linden P, Ickx BE. The effects of colloid solutions on hemostasis. Can J Anaesth 2006;53:S30-S39.
31. Stögermüller B, Stark J, Willschke H, et al. The effect of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000;91:823-827.
32. Treib J, Baron JF. Hydroxethyl starch: effects on hemostasis [in French]. Ann Fr Anesth Reanim 1998;17:72-81.
33. Strauss RG, Pennell BJ, Stump DC. A randomized, blinded trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 2002;42:27-36.
34. Clancey N, Burton S, Horney B, et al. Evaluation of platelet function in dogs with cardiac disease using the PFA-100 platelet 1function analyzer. Vet Clin Pathol 2009;38:299-305.
35. Jilma B. Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001;138:152-163.
36. Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008;34:709-733.
37. Lutze G, Kropf S. Bleeding time in vitro measured by the PFA- 100 system: pre-analytical conditions for blood collection [in German]. J Lab Med 2004;28:463-469.
38. Heilmann EJ, Kundu SK, Sio R, et al. Comparison of four commercial citrate blood collection systems for platelet function analysis by the PFA-100 system. Thromb Res 1997;87:159-164.
39. Godier A, Durand M, Smadja D, et al. Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference? Acta Anaesthesiol Scand 2010;54:1241-1247.
40. Liu FC, Liao CH, Chang YW, et al. Hydroxyethyl starch interferes with human blood ex vivo coagulation, platelet function and sedimentation. Acta Anaesthesiol Taiwan 2009;47:71-78.
41. Scharbert G, Deusch E, Kress HG, et al. Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesia. Anesth Analg 2004;99:823-827.
42. Sümpelmann R, Kretz FJ, Gäbler R, et al. Hydroxyethyl starch 130/0.42/6:1 for perioperative plasma volume replacement in children: preliminary results of a European prospective multicenter observational postauthorization safety study (PASS). Paediatr Anaesth 2008;18:929-933.
43. Chohan AS, Greene SA, Grubb TL, et al. Effects of 6% hetastarch (600/0.75) or lactated Ringer's solution on hemostatic variables and clinical bleeding in healthy dogs anesthetized for orthopedic surgery. Vet Anaesth Analg 2011;38:94-105.